Home » Posts tagged with » Richard J. Kang
NeuroBo, Gemphire merger wrapped up to form neurodegenerative disease company

NeuroBo, Gemphire merger wrapped up to form neurodegenerative disease company

NeuroBo Pharmaceuticals,  a Boston-based clinical-stage pharma company, has wrapped up its previously announced merger with Gemphire Therapeutics, a Michigan-based clinical-stage biopharma company focused on developing therapies for dyslipidemia and nonalcoholic fatty liver disease (NASH). The new combined company will be called NeuroBo Pharmaceuticals, which will focus on advancing a clinical-stage pipeline targeting neurodegenerative diseases. NeuroBo, […]